Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.
Upadhyaya HP, Desaiah D, Schuh KJ, Bymaster FP, Kallman MJ, Clarke DO, Durell TM, Trzepacz PT, Calligaro DO, Nisenbaum ES, Emmerson PJ, Schuh LM, Bickel WK, Allen AJ. Upadhyaya HP, et al. Among authors: calligaro do. Psychopharmacology (Berl). 2013 Mar;226(2):189-200. doi: 10.1007/s00213-013-2986-z. Epub 2013 Feb 9. Psychopharmacology (Berl). 2013. PMID: 23397050 Free PMC article. Review.
Muscarinic mechanisms of antipsychotic atypicality.
Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, Mckinzie DL. Bymaster FP, et al. Among authors: calligaro do. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1125-43. doi: 10.1016/j.pnpbp.2003.09.008. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642972 Review.
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.
Kennedy JS, Bymaster FP, Schuh L, Calligaro DO, Nomikos G, Felder CC, Bernauer M, Kinon BJ, Baker RW, Hay D, Roth HJ, Dossenbach M, Kaiser C, Beasley CM, Holcombe JH, Effron MB, Breier A. Kennedy JS, et al. Among authors: calligaro do. Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S33-61. doi: 10.1002/1099-1166(200112)16:1+<::aid-gps571>3.0.co;2-5. Int J Geriatr Psychiatry. 2001. PMID: 11748788 Review.
Olanzapine: a basic science update.
Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA, Calligaro DO. Bymaster F, et al. Among authors: calligaro do. Br J Psychiatry Suppl. 1999;(37):36-40. Br J Psychiatry Suppl. 1999. PMID: 10211140 Review.
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Rasmussen K, Benvenga MJ, Bymaster FP, Calligaro DO, Cohen IR, Falcone JF, Hemrick-Luecke SK, Martin FM, Moore NA, Nisenbaum LK, Schaus JM, Sundquist SJ, Tupper DE, Wiernicki TR, Nelson DL. Rasmussen K, et al. Among authors: calligaro do. J Pharmacol Exp Ther. 2005 Dec;315(3):1265-77. doi: 10.1124/jpet.105.089326. Epub 2005 Sep 1. J Pharmacol Exp Ther. 2005. PMID: 16141369
66 results